Carisma Therapeutics Inc. Earnings Per Share (Diluted)
Carisma Therapeutics Inc. reported Earnings Per Share (Diluted) of $1.07 per share for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2025-11-12
- Carisma Therapeutics Inc. earnings per share, diluted for the quarter ending 2025-09-30 was $1.07.
- Carisma Therapeutics Inc. earnings per share, diluted for the quarter ending 2025-06-30 was -$0.23.
- Carisma Therapeutics Inc. earnings per share, diluted for the quarter ending 2025-03-31 was -$0.22.
- Carisma Therapeutics Inc. earnings per share, diluted for the quarter ending 2024-09-30 was -$0.31.
- Carisma Therapeutics Inc. earnings per share, diluted for fiscal 2024 was -$1.46.
- Carisma Therapeutics Inc. earnings per share, diluted for fiscal 2023 was -$2.59.
- Carisma Therapeutics Inc. earnings per share, diluted for fiscal 2022 was -$28.77.
- Carisma Therapeutics Inc. earnings per share, diluted for fiscal 2021 was $0.00.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 3 month as first filed | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 6 month as first filed | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 9 month as first filed | Earnings Per Share, Diluted 12 month | Earnings Per Share, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | $1.07 10-Q · filed 2025-11-12 | $0.61 10-Q · filed 2025-11-12 | ||||||
| 2025-06-30 | -$0.23 10-Q · filed 2025-08-07 | -$0.46 10-Q · filed 2025-08-07 | ||||||
| 2025-03-31 | -$0.22 10-Q · filed 2025-05-13 | |||||||
| 2024-12-31 | -$1.46 10-K · filed 2025-03-31 | |||||||
| 2024-09-30 | -$0.31 10-Q · filed 2025-11-12 | -$1.04 10-Q · filed 2025-11-12 | ||||||
| 2024-06-30 | -$0.27 10-Q · filed 2025-08-07 | -$0.73 10-Q · filed 2025-08-07 | ||||||
| 2024-03-31 | -$0.46 10-Q · filed 2025-05-13 | |||||||
| 2023-12-31 | -$2.59 10-K · filed 2025-03-31 | |||||||
| 2023-09-30 | -$0.53 10-Q · filed 2024-11-07 | -$2.11 10-Q · filed 2024-11-07 | ||||||
| 2023-06-30 | -$0.49 10-Q · filed 2024-08-08 | -$1.67 10-Q · filed 2024-08-08 | ||||||
| 2023-03-31 | -$1.93 10-Q · filed 2024-05-09 | |||||||
| 2022-12-31 | -$3.44 derived: net income ÷ weighted average shares · filed 2024-04-01 | $5.86 derived: net income ÷ weighted average shares · filed 2024-04-01 | -$8.88 derived: net income ÷ weighted average shares · filed 2024-04-01 | -$28.77 10-K · filed 2024-04-01 | -$0.10 10-K · filed 2023-02-28 | |||
| 2022-09-30 | -$8.37 10-Q · filed 2023-11-09 | $0.10 10-Q · filed 2022-11-07 | -$5.42 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$21.14 10-Q · filed 2023-11-09 | -$0.06 10-Q · filed 2022-11-07 | -$0.07 derived: net income ÷ weighted average shares · filed 2023-11-09 | ||
| 2022-06-30 | -$7.20 10-Q · filed 2023-08-10 | -$0.16 10-Q · filed 2022-08-08 | -$12.69 10-Q · filed 2023-08-10 | -$0.16 10-Q · filed 2022-08-08 | -$0.35 derived: net income ÷ weighted average shares · filed 2023-08-10 | $0.47 derived: net income ÷ weighted average shares · filed 2023-08-10 | ||
| 2022-03-31 | -$5.49 10-Q · filed 2023-05-11 | $0.00 10-Q · filed 2022-05-09 | $0.08 derived: net income ÷ weighted average shares · filed 2023-05-11 | $0.59 derived: net income ÷ weighted average shares · filed 2023-05-11 | $0.38 derived: net income ÷ weighted average shares · filed 2023-05-11 | |||
| 2021-12-31 | $0.04 derived: net income ÷ weighted average shares · filed 2023-02-28 | $0.40 derived: net income ÷ weighted average shares · filed 2023-02-28 | $0.29 derived: net income ÷ weighted average shares · filed 2023-02-28 | $0.00 10-K · filed 2023-02-28 | ||||
| 2021-09-30 | $0.36 10-Q · filed 2022-11-07 | $0.25 derived: net income ÷ weighted average shares · filed 2022-11-07 | -$0.05 10-Q · filed 2022-11-07 | -$0.15 derived: net income ÷ weighted average shares · filed 2023-02-28 | ||||
| 2021-06-30 | -$0.15 10-Q/A · filed 2022-08-25 | -$0.49 10-Q/A · filed 2022-08-25 | -$0.62 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$0.81 derived: net income ÷ weighted average shares · filed 2023-02-28 | ||||
| 2021-03-31 | -$0.35 10-Q · filed 2022-05-09 | -$0.49 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$0.69 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$0.92 derived: net income ÷ weighted average shares · filed 2023-02-28 | ||||
| 2020-12-31 | -$0.11 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$0.30 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$0.53 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$0.19 10-K · filed 2023-02-28 | ||||
| 2020-09-30 | -$0.19 10-Q · filed 2021-11-08 | -$0.43 derived: net income ÷ weighted average shares · filed 2021-11-08 | -$0.07 10-Q · filed 2021-11-08 | |||||
| 2020-06-30 | -$0.24 10-Q · filed 2021-08-09 | $0.11 10-Q · filed 2021-08-09 | ||||||
| 2020-03-31 | $0.31 10-Q · filed 2021-05-10 | |||||||
| 2019-12-31 | -$1.18 10-K · filed 2022-02-28 | |||||||
| 2019-06-30 | -$0.67 10-Q · filed 2020-08-10 | -$0.77 10-Q · filed 2020-08-10 | ||||||
| 2019-03-31 | -$0.08 10-Q · filed 2020-05-11 | |||||||
| 2018-12-31 | -$0.55 10-K · filed 2019-03-01 | |||||||
| 2017-12-31 | -$1.11 10-K · filed 2019-03-01 | |||||||
| 2017-09-30 | -$0.37 10-Q · filed 2017-11-17 | -$0.91 10-Q · filed 2017-11-17 | ||||||
| 2016-12-31 | -$0.15 10-K · filed 2018-04-02 | $0.09 10-K · filed 2019-03-01 | ||||||
| 2016-09-30 | $0.91 10-K · filed 2018-04-02 | $0.26 10-Q · filed 2017-11-17 | ||||||
| 2016-06-30 | -$0.33 10-K · filed 2018-04-02 | |||||||
| 2016-03-31 | -$0.39 10-K · filed 2018-04-02 | |||||||
| 2015-12-31 | -$1.76 10-K · filed 2018-04-02 | |||||||
| 2015-09-30 | -$0.50 10-Q · filed 2016-11-14 | -$1.23 10-Q · filed 2016-11-14 | ||||||
| 2014-12-31 | -$2.37 10-K · filed 2017-03-24 |